Patent · US Active

Growth differentiation factor 15 (GDF-15) polypeptides

US10336798B2 · kind B2 · utility

9Cited by
9References
21Claims
0Family size

Inventors

Key dates

Filing dateJun 16, 2017
Grant dateJul 2, 2019
Priority date
Expiry dateJun 16, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

GDF15 polypeptides, constructs comprising GDF15, and mutants thereof are provided. In various embodiments the GDF15 polypeptides, constructs comprising GDF15, and mutants thereof, can be of use in the treatment or ameliorating a metabolic disorder. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.